Edition:
India

Janus Henderson Group PLC (JHG.N)

JHG.N on New York Stock Exchange

32.50USD
12:47am IST
Change (% chg)

$-0.08 (-0.25%)
Prev Close
$32.58
Open
$32.57
Day's High
$32.67
Day's Low
$32.21
Volume
94,253
Avg. Vol
232,777
52-wk High
$41.61
52-wk Low
$30.35

Chart for

About

Janus Henderson Group plc, formerly Henderson Group plc, is an independent asset manager, specializing in active investment. The Company is a client-focused global business with assets under management. It manages a range of actively managed investment products for institutional and retail investors, across five capabilities,... (more)

Overall

Beta: --
Market Cap(Mil.): $6,529.23
Shares Outstanding(Mil.): 200.41
Dividend: 0.36
Yield (%): 4.42

Financials

BRIEF-Janus Henderson Group says Janus Detroit Street Trust Board Of Trustee's Approved Plan To Liquidate Janus Velocity Tail Risk Hedged Large Cap ETF

* JANUS HENDERSON GROUP - JANUS DETROIT STREET TRUST BOARD OF TRUSTEE'S APPROVED PLAN TO LIQUIDATE JANUS VELOCITY TAIL RISK HEDGED LARGE CAP ETF

06 Mar 2018

UPDATE 4-Credit Suisse 'volatility' fund liquidated after market selloff

ZURICH/NEW YORK, Feb 6 Credit Suisse said on Tuesday it would terminate the second-largest publicly traded product betting on future swings in the S&P 500 after its value plunged during the global market rout.

07 Feb 2018

Janus Henderson co-CEO: Market falls a 'not unhealthy' correction

LONDON Fund manager Janus Henderson's co-Chief Executive Andrew Formica said a market sell-off on fears of rising inflation was a "not unhealthy" pull-back as opposed to the start of a more sustained selloff.

06 Feb 2018

Janus Henderson co-CEO: Market falls a "not unhealthy" correction

LONDON, Feb 6 Fund manager Janus Henderson's co-Chief Executive Andrew Formica said a market sell-off on fears of rising inflation was a "not unhealthy" pull-back as opposed to the start of a more sustained selloff.

06 Feb 2018

BRIEF-Janus Henderson Group Reports 10.1 Pct Passive Stake In Collegium Pharmaceutical

* JANUS HENDERSON GROUP PLC REPORTS 10.1 PERCENT PASSIVE STAKE IN COLLEGIUM PHARMACEUTICAL AS OF DEC 31, 2017 - SEC FILING Source text : [http://bit.ly/2mvIp5l] Further company coverage:

11 Jan 2018

Earnings vs. Estimates